Blonder Tongue Laboratories Inc
BDR was delisted on the 24th of June, 2022.
7 hedge funds and large institutions have $280K invested in Blonder Tongue Laboratories Inc in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
36% less capital invested
Capital invested by funds: $436K → $280K (-$156K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.38K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$905 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$17K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.85K |
| 3 |
Renaissance Technologies
New York
|
-$4.59K |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.59K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
1
Bridgeway Capital Management
Houston,
Texas
| $205K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $47K | -$4.59K | -5,600 | -7% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $11K | – | – | – |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $10K | -$5.85K | -7,146 | -31% |
|
|
5
UBS Group
Zurich,
Switzerland
| $5K | +$3.38K | +4,131 | +148% |
|
|
6
Federated Hermes
Pittsburgh,
Pennsylvania
| $1K | -$1.59K | -1,942 | -68% |
|
|
7
Bank of America
Charlotte,
North Carolina
| $1K | +$905 | +1,105 | New |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$17K | -17,394 | Closed |
|
BDR Hedge Fund Activity: Q3 2019 in Review
7 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Blonder Tongue Laboratories Inc (BDR) for Q3 2019, worth a combined $280K — down 36% from $436K a quarter earlier.
Fund positioning in BDR was balanced in Q3 2019: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, adding an estimated $3.38K. The largest seller was Citadel Advisors, exiting entirely with an estimated $17K sold.
- 7 institutional investors held Blonder Tongue Laboratories Inc (BDR) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $280K of Blonder Tongue Laboratories Inc stock for Q3 2019, down 36% quarter-over-quarter.
- 1 fund opened new Blonder Tongue Laboratories Inc positions in Q3 2019 and 1 closed out, a net change of 0 holders.
- The largest Blonder Tongue Laboratories Inc buyer in Q3 2019 was UBS Group, an estimated $3.38K added.
- The largest Blonder Tongue Laboratories Inc seller in Q3 2019 was Citadel Advisors, an estimated $17K sold.
Based on aggregated 13F filings for Q3 2019.